Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Long-Term Deferred Tax (2023 - 2025)

Historic Long-Term Deferred Tax for Sunshine Biopharma (SBFM) over the last 3 years, with Q3 2025 value amounting to $92234.0.

  • Sunshine Biopharma's Long-Term Deferred Tax changed N/A to $92234.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $92234.0, marking a year-over-year change of. This contributed to the annual value of $92234.0 for FY2024, which is 4782.08% down from last year.
  • Per Sunshine Biopharma's latest filing, its Long-Term Deferred Tax stood at $92234.0 for Q3 2025.
  • Over the past 5 years, Sunshine Biopharma's Long-Term Deferred Tax peaked at $176764.0 during Q4 2023, and registered a low of $92234.0 during Q4 2024.
  • In the last 3 years, Sunshine Biopharma's Long-Term Deferred Tax had a median value of $92234.0 in 2024 and averaged $109140.0.
  • Within the past 5 years, the most significant YoY rise in Sunshine Biopharma's Long-Term Deferred Tax was 4782.08% (2024), while the steepest drop was 4782.08% (2024).
  • Quarter analysis of 3 years shows Sunshine Biopharma's Long-Term Deferred Tax stood at $176764.0 in 2023, then plummeted by 47.82% to $92234.0 in 2024, then changed by 0.0% to $92234.0 in 2025.
  • Its Long-Term Deferred Tax was $92234.0 in Q3 2025, compared to $92234.0 in Q2 2025 and $92234.0 in Q1 2025.